MyAverix Finance
ST · Healthcare
Enorama Pharma AB (ERMA)
Drug Manufacturers - Specialty & Generic
Enorama Pharma AB (ERMA) is listed on ST in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ERMA
Enorama Pharma AB (ERMA) — FAQ
What is ERMA's P/E ratio?
The price-to-earnings (P/E) ratio for Enorama Pharma AB (ERMA) is 18.00 (data as of 2026-05-24).
Does Enorama Pharma AB pay a dividend?
Dividend yield is not available in the current snapshot for Enorama Pharma AB (ERMA). Check the MyAverix Finance app for the latest dividend data.
What sector is Enorama Pharma AB in?
Enorama Pharma AB (ERMA) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is ERMA listed on?
ERMA is listed on ST.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.